Cargando…

Brief assessment of male depression in clinical care: Validation of the Male Depression Risk Scale short form in a cross-sectional study of Australian men

OBJECTIVES: To develop and validate a short form of the Male Depression Risk Scale (MDRS-22) for use in primary care, examining associations with prototypic depression symptoms, psychological distress and suicidality. DESIGN: Cross-sectional study with 8-month follow-up. SETTING: Community-based. PA...

Descripción completa

Detalles Bibliográficos
Autores principales: Herreen, Danielle, Rice, Simon, Zajac, Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961138/
https://www.ncbi.nlm.nih.gov/pubmed/35351704
http://dx.doi.org/10.1136/bmjopen-2021-053650
_version_ 1784677532442820608
author Herreen, Danielle
Rice, Simon
Zajac, Ian
author_facet Herreen, Danielle
Rice, Simon
Zajac, Ian
author_sort Herreen, Danielle
collection PubMed
description OBJECTIVES: To develop and validate a short form of the Male Depression Risk Scale (MDRS-22) for use in primary care, examining associations with prototypic depression symptoms, psychological distress and suicidality. DESIGN: Cross-sectional study with 8-month follow-up. SETTING: Community-based. PARTICIPANTS: A community sample of younger (n=510; 18–64 years) and older (n=439; 65–93 years) men residing in Australia (M age=58.09 years, SD=17.77) participated in the study. A subset of respondents (n=159 younger men; n=169 older men) provided follow-up data approximately eight months later. PRIMARY AND SECONDARY OUTCOME MEASURES: Quantitative data were obtained through a survey comprising a range of validated measures, including the MDRS-22, the Patient Health Questionnaire (PHQ-9) and the Kessler Psychological Distress Scale (K10). The MDRS-22 was refined using exploratory and confirmatory factor analysis in line with best practice guidelines. Analysis of variance and generalised linear models were conducted to explore relationships between variables. RESULTS: The short-form MDRS consisted of seven items (MDRS-7) and captured all of the domains in the original tool. Participants with mixed symptoms (PHQ-9 ≥ 10 and MDRS-7 > 5) had significantly higher risk of mental illness (K10 ≥ 25) and current suicidality (PHQ-9 item 9 ≥ 1) than those with exclusively prototypic symptoms (PHQ-9 ≥ 10 and MDRS-7 ≤ 5). Furthermore, the MDRS-7 was shown to be effective at predicting elevated symptoms of depression at follow-up, after controlling for previous depression diagnosis. CONCLUSIONS: Findings provide preliminary evidence of the potential utility of the MDRS-7 as a screening tool for externalised and male-type symptoms associated with major depression in men. Field trials of the MDRS-7 in primary care settings may facilitate identification of men at risk of suicide and psychological distress who do not meet cut-off scores for existing measures of major depression symptoms.
format Online
Article
Text
id pubmed-8961138
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-89611382022-04-11 Brief assessment of male depression in clinical care: Validation of the Male Depression Risk Scale short form in a cross-sectional study of Australian men Herreen, Danielle Rice, Simon Zajac, Ian BMJ Open Mental Health OBJECTIVES: To develop and validate a short form of the Male Depression Risk Scale (MDRS-22) for use in primary care, examining associations with prototypic depression symptoms, psychological distress and suicidality. DESIGN: Cross-sectional study with 8-month follow-up. SETTING: Community-based. PARTICIPANTS: A community sample of younger (n=510; 18–64 years) and older (n=439; 65–93 years) men residing in Australia (M age=58.09 years, SD=17.77) participated in the study. A subset of respondents (n=159 younger men; n=169 older men) provided follow-up data approximately eight months later. PRIMARY AND SECONDARY OUTCOME MEASURES: Quantitative data were obtained through a survey comprising a range of validated measures, including the MDRS-22, the Patient Health Questionnaire (PHQ-9) and the Kessler Psychological Distress Scale (K10). The MDRS-22 was refined using exploratory and confirmatory factor analysis in line with best practice guidelines. Analysis of variance and generalised linear models were conducted to explore relationships between variables. RESULTS: The short-form MDRS consisted of seven items (MDRS-7) and captured all of the domains in the original tool. Participants with mixed symptoms (PHQ-9 ≥ 10 and MDRS-7 > 5) had significantly higher risk of mental illness (K10 ≥ 25) and current suicidality (PHQ-9 item 9 ≥ 1) than those with exclusively prototypic symptoms (PHQ-9 ≥ 10 and MDRS-7 ≤ 5). Furthermore, the MDRS-7 was shown to be effective at predicting elevated symptoms of depression at follow-up, after controlling for previous depression diagnosis. CONCLUSIONS: Findings provide preliminary evidence of the potential utility of the MDRS-7 as a screening tool for externalised and male-type symptoms associated with major depression in men. Field trials of the MDRS-7 in primary care settings may facilitate identification of men at risk of suicide and psychological distress who do not meet cut-off scores for existing measures of major depression symptoms. BMJ Publishing Group 2022-03-28 /pmc/articles/PMC8961138/ /pubmed/35351704 http://dx.doi.org/10.1136/bmjopen-2021-053650 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Mental Health
Herreen, Danielle
Rice, Simon
Zajac, Ian
Brief assessment of male depression in clinical care: Validation of the Male Depression Risk Scale short form in a cross-sectional study of Australian men
title Brief assessment of male depression in clinical care: Validation of the Male Depression Risk Scale short form in a cross-sectional study of Australian men
title_full Brief assessment of male depression in clinical care: Validation of the Male Depression Risk Scale short form in a cross-sectional study of Australian men
title_fullStr Brief assessment of male depression in clinical care: Validation of the Male Depression Risk Scale short form in a cross-sectional study of Australian men
title_full_unstemmed Brief assessment of male depression in clinical care: Validation of the Male Depression Risk Scale short form in a cross-sectional study of Australian men
title_short Brief assessment of male depression in clinical care: Validation of the Male Depression Risk Scale short form in a cross-sectional study of Australian men
title_sort brief assessment of male depression in clinical care: validation of the male depression risk scale short form in a cross-sectional study of australian men
topic Mental Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961138/
https://www.ncbi.nlm.nih.gov/pubmed/35351704
http://dx.doi.org/10.1136/bmjopen-2021-053650
work_keys_str_mv AT herreendanielle briefassessmentofmaledepressioninclinicalcarevalidationofthemaledepressionriskscaleshortforminacrosssectionalstudyofaustralianmen
AT ricesimon briefassessmentofmaledepressioninclinicalcarevalidationofthemaledepressionriskscaleshortforminacrosssectionalstudyofaustralianmen
AT zajacian briefassessmentofmaledepressioninclinicalcarevalidationofthemaledepressionriskscaleshortforminacrosssectionalstudyofaustralianmen